Outset Medical
100 hedge funds and large institutions have $58.1M invested in Outset Medical in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 21 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 26
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 101 → 100 (-1)
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
14.66% less ownership
Funds ownership: 100.36% → 85.7% (-15%)
77% less capital invested
Capital invested by funds: $253M → $58.1M (-$195M)
98% less call options, than puts
Call options by funds: $9K | Put options by funds: $570K
Top Buyers
Top Sellers
OM Hedge Fund Activity: Q4 2025 in Review
100 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2025, worth a combined $58.1M — down 77% from $253M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of OM and 20 opened new positions — a net loss of 1 holder — while 26 trimmed existing stakes and 34 added.
The largest buyer was Bank of America, adding an estimated $7.96M. The largest seller was Durable Capital Partners, exiting entirely with an estimated $14.5M sold.
- 100 institutional investors held Outset Medical (OM) as of Q4 2025, down from 101 in Q3 2025.
- Funds reported $58.1M of Outset Medical stock for Q4 2025, down 77% quarter-over-quarter.
- 20 funds opened new Outset Medical positions in Q4 2025 and 21 closed out, a net change of -1 holder.
- The largest Outset Medical buyer in Q4 2025 was Bank of America, an estimated $7.96M added.
- The largest Outset Medical seller in Q4 2025 was Durable Capital Partners, an estimated $14.5M sold.
Based on aggregated 13F filings for Q4 2025.